SMS Lifesciences India Limited (SMSLIFE.BO)
INR 1431.3
(12.48%)
INR 1431.3
(12.48%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 90.92 Million INR | -20.68% |
| 2022 | 114.62 Million INR | -54.73% |
| 2021 | 253.22 Million INR | 86.79% |
| 2020 | 135.56 Million INR | 33.13% |
| 2019 | 101.83 Million INR | -42.94% |
| 2018 | 178.47 Million INR | 174.52% |
| 2017 | 65.01 Million INR | -49.77% |
| 2016 | 129.43 Million INR | 699732.43% |
| 2015 | -18.5 Thousand INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 69.98 Million INR | 18.53% |
| 2023 Q3 | 43.04 Million INR | 545.96% |
| 2023 FY | 90.92 Million INR | -20.68% |
| 2023 Q2 | 6.66 Million INR | 137.12% |
| 2023 Q1 | -17.95 Million INR | -204.57% |
| 2023 Q4 | 59.04 Million INR | 37.18% |
| 2022 Q2 | 27.51 Million INR | -8.54% |
| 2022 Q3 | 39.87 Million INR | 44.9% |
| 2022 Q4 | 17.16 Million INR | -56.95% |
| 2022 Q1 | 30.08 Million INR | -66.99% |
| 2022 FY | 114.62 Million INR | -54.73% |
| 2021 Q4 | 91.12 Million INR | 291.26% |
| 2021 FY | 253.22 Million INR | 86.79% |
| 2021 Q2 | 102.52 Million INR | 182.62% |
| 2021 Q1 | 36.27 Million INR | -28.22% |
| 2021 Q3 | 23.29 Million INR | -77.28% |
| 2020 Q2 | 33.14 Million INR | 33.53% |
| 2020 FY | 135.56 Million INR | 33.13% |
| 2020 Q1 | 24.82 Million INR | 19.26% |
| 2020 Q3 | 26.95 Million INR | -18.69% |
| 2020 Q4 | 50.53 Million INR | 87.49% |
| 2019 Q2 | 36.81 Million INR | -22.0% |
| 2019 FY | 101.83 Million INR | -42.94% |
| 2019 Q4 | 20.81 Million INR | 713.71% |
| 2019 Q3 | -3.39 Million INR | -109.21% |
| 2019 Q1 | 47.19 Million INR | -10.3% |
| 2018 Q1 | 30.71 Million INR | 55.81% |
| 2018 FY | 178.47 Million INR | 174.52% |
| 2018 Q4 | 52.61 Million INR | -7.26% |
| 2018 Q3 | 56.73 Million INR | 28.64% |
| 2018 Q2 | 44.1 Million INR | 43.59% |
| 2017 Q3 | 24.75 Million INR | 143.71% |
| 2017 Q4 | 19.71 Million INR | -20.37% |
| 2017 FY | 65.01 Million INR | -49.77% |
| 2017 Q1 | 10.38 Million INR | -64.98% |
| 2017 Q2 | 10.15 Million INR | -2.14% |
| 2016 Q1 | 46.9 Million INR | 0.0% |
| 2016 Q3 | 43.37 Million INR | 147.74% |
| 2016 Q2 | 17.5 Million INR | -62.67% |
| 2016 FY | 129.43 Million INR | 699732.43% |
| 2016 Q4 | 29.64 Million INR | -31.67% |
| 2015 FY | -18.5 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 2.76 Million INR | -3189.725% |
| Biocon Limited | 10.22 Billion INR | 99.111% |
| Blue Jet Healthcare Limited | 1.63 Billion INR | 94.447% |
| Concord Biotech Limited | 3.08 Billion INR | 97.049% |
| Dishman Carbogen Amcis Limited | -1.53 Billion INR | 105.926% |
| FERMENTA BIOTECH LIMITED | -230.59 Million INR | 139.431% |
| GENOMIC VALLEY BIOTECH LIMITED | 151.81 Thousand INR | -59792.766% |
| Lyka Labs Limited | -24.89 Million INR | 465.261% |
| Panacea Biotec Limited | -11.73 Million INR | 875.175% |
| SAMSRITA LABS LIMITED | -2.62 Million INR | 3567.292% |
| Servoteach Industries Limited | -2.37 Million INR | 3930.16% |
| Supriya Lifescience Limited | 1.19 Billion INR | 92.366% |
| Syngene International Limited | 5.1 Billion INR | 98.217% |
| TAKE Solutions Limited | -1.19 Billion INR | 107.601% |
| Titan Biotech Limited | 248.53 Million INR | 63.414% |
| Transgene Biotek Limited | -6.55 Million INR | 1487.155% |
| Vanta Bioscience Limited | -23.15 Million INR | 492.625% |